Annual CAPEX
$178.00 K
-$145.00 K-44.89%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual capital expenditures is $178.00 thousand, with the most recent change of -$145.00 thousand (-44.89%) on December 31, 2022.
- During the last 3 years, EGRX annual CAPEX has fallen by -$599.00 thousand (-77.09%).
- EGRX annual CAPEX is now -99.14% below its all-time high of $20.69 million, reached on December 31, 2016.
Performance
EGRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$6000.00
-$52.00 K-89.66%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly capital expenditures is $6000.00, with the most recent change of -$52.00 thousand (-89.66%) on June 30, 2023.
- Over the past year, EGRX quarterly CAPEX has increased by +$6000.00 (+100.00%).
- EGRX quarterly CAPEX is now -99.96% below its all-time high of $14.18 million, reached on September 30, 2016.
Performance
EGRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$74.00 K
+$6000.00+8.82%
June 30, 2023
Summary
- As of February 8, 2025, EGRX TTM capital expenditures is $74.00 thousand, with the most recent change of +$6000.00 (+8.82%) on June 30, 2023.
- Over the past year, EGRX TTM CAPEX has dropped by -$148.00 thousand (-66.67%).
- EGRX TTM CAPEX is now -99.64% below its all-time high of $20.69 million, reached on December 31, 2016.
Performance
EGRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EGRX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.9% | +100.0% | -66.7% |
| 3 y3 years | -77.1% | +106.3% | -90.9% |
| 5 y5 years | -96.6% | +100.0% | -90.5% |
EGRX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.9% | at low | -96.4% | -100.0% | -77.1% | +8.8% |
| 5 y | 5-year | -77.1% | at low | -98.7% | +105.2% | -93.1% | +8.8% |
| alltime | all time | -99.1% | +439.4% | -100.0% | +105.2% | -99.6% | +141.0% |
Eagle Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $6000.00(-89.7%) | $74.00 K(+8.8%) |
| Mar 2023 | - | $58.00 K(+480.0%) | $68.00 K(-61.8%) |
| Dec 2022 | $178.00 K(-44.9%) | $10.00 K(>+9900.0%) | $178.00 K(-18.0%) |
| Sep 2022 | - | $0.00(0.0%) | $217.00 K(-2.3%) |
| Jun 2022 | - | $0.00(-100.0%) | $222.00 K(+107.5%) |
| Mar 2022 | - | $168.00 K(+242.9%) | $107.00 K(-66.9%) |
| Dec 2021 | $323.00 K(-56.8%) | $49.00 K(+880.0%) | $323.00 K(-27.3%) |
| Sep 2021 | - | $5000.00(-104.3%) | $444.00 K(-30.6%) |
| Jun 2021 | - | -$115.00 K(-129.9%) | $640.00 K(-2.9%) |
| Mar 2021 | - | $384.00 K(+125.9%) | $659.00 K(-11.8%) |
| Dec 2020 | $747.00 K(-3.9%) | $170.00 K(-15.4%) | $747.00 K(+5.7%) |
| Sep 2020 | - | $201.00 K(-309.4%) | $707.00 K(-12.7%) |
| Jun 2020 | - | -$96.00 K(-120.3%) | $810.00 K(-24.4%) |
| Mar 2020 | - | $472.00 K(+263.1%) | $1.07 M(+38.0%) |
| Dec 2019 | $777.00 K(+484.2%) | $130.00 K(-57.2%) | $777.00 K(+6.7%) |
| Sep 2019 | - | $304.00 K(+83.1%) | $728.00 K(+59.3%) |
| Jun 2019 | - | $166.00 K(-6.2%) | $457.00 K(+57.0%) |
| Mar 2019 | - | $177.00 K(+118.5%) | $291.00 K(+118.8%) |
| Dec 2018 | $133.00 K | $81.00 K(+145.5%) | $133.00 K(-95.2%) |
| Sep 2018 | - | $33.00 K(>+9900.0%) | $2.78 M(-35.6%) |
| Jun 2018 | - | $0.00(-100.0%) | $4.32 M(-4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $19.00 K(-99.3%) | $4.53 M(-12.7%) |
| Dec 2017 | $5.19 M(-74.9%) | $2.73 M(+73.7%) | $5.19 M(-35.7%) |
| Sep 2017 | - | $1.57 M(+655.8%) | $8.06 M(-61.0%) |
| Jun 2017 | - | $208.00 K(-69.2%) | $20.67 M(+0.5%) |
| Mar 2017 | - | $676.00 K(-87.9%) | $20.56 M(-0.6%) |
| Dec 2016 | $20.69 M(+999.9%) | $5.61 M(-60.5%) | $20.69 M(+32.9%) |
| Sep 2016 | - | $14.18 M(>+9900.0%) | $15.57 M(+533.3%) |
| Jun 2016 | - | $100.00 K(-87.6%) | $2.46 M(-7.0%) |
| Mar 2016 | - | $804.00 K(+66.5%) | $2.64 M(+40.5%) |
| Dec 2015 | $1.88 M(+3989.1%) | $483.00 K(-54.9%) | $1.88 M(+33.5%) |
| Sep 2015 | - | $1.07 M(+277.1%) | $1.41 M(+308.2%) |
| Jun 2015 | - | $284.00 K(+560.5%) | $345.20 K(+427.8%) |
| Mar 2015 | - | $43.00 K(+290.9%) | $65.40 K(+30.8%) |
| Dec 2014 | - | $11.00 K(+52.8%) | $50.00 K(+8.7%) |
| Sep 2014 | $46.00 K(+12.2%) | $7200.00(+71.4%) | $46.00 K(-6.3%) |
| Jun 2014 | - | $4200.00(-84.8%) | $49.10 K(-35.1%) |
| Mar 2014 | - | $27.60 K(+294.3%) | $75.60 K(+57.5%) |
| Dec 2013 | - | $7000.00(-32.0%) | $48.00 K(+17.1%) |
| Sep 2013 | $41.00 K(+24.2%) | $10.30 K(-66.4%) | $41.00 K(+33.6%) |
| Jun 2013 | - | $30.70 K | $30.70 K |
| Sep 2012 | $33.00 K | - | - |
FAQ
- What is Eagle Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual CAPEX year-on-year change?
- What is Eagle Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Eagle Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals TTM CAPEX year-on-year change?
What is Eagle Pharmaceuticals annual capital expenditures?
The current annual CAPEX of EGRX is $178.00 K
What is the all time high annual CAPEX for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual capital expenditures is $20.69 M
What is Eagle Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, EGRX annual capital expenditures has changed by -$145.00 K (-44.89%)
What is Eagle Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of EGRX is $6000.00
What is the all time high quarterly CAPEX for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly capital expenditures is $14.18 M
What is Eagle Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, EGRX quarterly capital expenditures has changed by +$6000.00 (+100.00%)
What is Eagle Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of EGRX is $74.00 K
What is the all time high TTM CAPEX for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high TTM capital expenditures is $20.69 M
What is Eagle Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, EGRX TTM capital expenditures has changed by -$148.00 K (-66.67%)